A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of trimetrexate glucuronate with leucovorin protection in
patients with Pneumocystis carinii pneumonia (PCP) who are refractory to or have demonstrated
severe or life-threatening toxicities to standard therapies (e.g., TMP/SMX or parenteral
pentamidine).